ArticleMediators of inflammation2026
Integrated Multiomics Elucidates Molecular Mechanisms of Bisphenol A in Exacerbating Crohn's Disease.
Article in Mediators of inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrated Multiomics Elucidates Molecular Mechanisms of Bisphenol A in Exacerbating Crohn's Disease.Mediators of inflammation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bisphenol A (BPA), a widespread environmental endocrine-disrupting chemical, has been associated with the development and progression of Crohn's disease (CD), yet its precise molecular mechanisms remain unclear. We aimed to systematically elucidate the potential molecular mechanisms by which BPA exacerbates CD and to identify key biomarkers and therapeutic targets. Methods: BPA-related targets and CD transcriptomic datasets (GSE36807, GSE75214, and GSE95095) were retrieved from public databases. Overlapping genes were identified and subjected to functional enrichment and protein-protein interaction (PPI) network analysis. Multiple machine learning algorithms were employed to screen for core genes, and molecular docking was used to validate the binding affinity between BPA and core proteins. Immune infiltration analysis and regulatory network construction were performed to explore the roles of core genes in the immune microenvironment and post-translational regulation. Results: A total of 65 overlapping genes between BPA and CD were identified, primarily enriched in pathways related to inflammation, apoptosis, and immune regulation. Machine learning screened five core genes (HGF, IL1R1, MMP1, MMP2, and NTRK2), which demonstrated strong diagnostic performance in independent datasets. Molecular docking revealed strong binding affinity between BPA and these proteins, with the lowest binding energy observed for MMP2 (-8.4 kcal/mol). Immune infiltration analysis indicated significant correlations between core genes and immune cell subsets such as Tr1, Th17, and Tfh cells. Regulatory network analysis identified key transcription factors (e.g., STAT3) and E3 ubiquitin ligases (e.g., SYVN1) involved in gene regulation. Conclusion: BPA may exacerbate CD progression by dysregulating core genes, such as HGF, IL1R1, MMP1, MMP2, and NTRK2, thereby disrupting inflammatory balance, extracellular matrix remodeling, and immune homeostasis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.